Lazard Asset Management’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Lazard Asset Management's HALO Position: Q2 2026 in Review
Lazard Asset Management increased its Halozyme (HALO) stake by 14% in Q2 2026, buying an estimated $978K and bringing the position to 117,360 shares worth $9.19M. The position accounts for 0.01% of the portfolio, ranked #459.
Lazard Asset Management first reported a position in HALO in Q3 2019 and has held it in 27 quarters since. The position peaked at $43.2M in Q2 2023. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Lazard Asset Management held 117,360 shares of Halozyme worth $9.19M as of Q2 2026.
- Lazard Asset Management bought 14,349 Halozyme shares in Q2 2026, an estimated $978K.
- Halozyme made up 0.01% of Lazard Asset Management's portfolio in Q2 2026, its #459 holding.
- Lazard Asset Management first reported a position in Halozyme in Q3 2019 and has held it in 27 quarters since.
- Lazard Asset Management's Halozyme position peaked at $43.2M in Q2 2023.
- 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Lazard Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.